Skip to content
WorldBrand.AI

Tencent Healthcare (China)

Controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile1 entries

  1. 2022

    Tencent fined RMB 500,000 by SAMR for failing to notify concentration in Sinyi Medical equity acquisition

    The State Administration for Market Regulation determined that Tencent Holdings' acquisition of equity in Shanghai Sinyi Medical Technology Co., Ltd. constituted illegal implementation of a concentration without lawful notification (with no effect of eliminating or restricting competition), and fined it RMB 500,000. Progress: administrative penalty. Subjects: Tencent Holdings Limited, Shanghai Sinyi Medical Technology Co., Ltd. Scope: healthcare investment.

    Source